Markets:

Overview

News

Currencies

International

Treasuries

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.4619 +0.0178 (+4.01%)

Streaming Delayed Price Updated: 9:48 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sangamo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

April 04, 2025

Via Benzinga

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday ↗

April 04, 2025

Via Benzinga

RH, Five Below, Sangamo, Bank Of America, Tesla: Why These 5 Stocks Are On Investors' Radars Amid Trump Tariff Meltdown ↗

April 03, 2025

The stock market experienced a significant downturn today, with the S&P 500 dropping nearly 5% to 5,396.52, marking its worst session since September 2022.

Via Benzinga

Topics Government Stocks

Expert Outlook: Sangamo Therapeutics Through The Eyes Of 11 Analysts ↗

January 27, 2025

Via Benzinga

9 Analysts Have This To Say About Sangamo Therapeutics ↗

December 31, 2024

Via Benzinga

Eli Lilly Stock Drops As Trump Tariff Chaos Hits Markets, But Retail Finds Comfort In Big Pharma’s Exemption ↗

April 03, 2025

On Stocktwits, message volume about Lilly jumped by 23% over the past 24 hours, with retail sentiment turning more ‘bullish.’

Via Stocktwits

Topics Government Stocks World Trade

What's going on in today's after hours session ↗

April 03, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 03, 2025

Via Benzinga

Sangamo Therapeutics Stock Surges After The Bell: What's Going On? ↗

April 03, 2025

Sangamo Therapeutics shares are surging in Thursday's after-hours session after the company announced a new agreement with pharmaceutical giant Eli Lilly And Co.

Via Benzinga

Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System

April 03, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

8 Analysts Assess Sangamo Therapeutics: What You Need To Know ↗

March 18, 2025

Via Benzinga

US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being' ↗

March 18, 2025

U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.

Via Benzinga

IHS Holding, HealthEquity And 3 Stocks To Watch Heading Into Tuesday ↗

March 18, 2025

Via Benzinga

Sangamo Therapeutics Retail Traders Keep The Faith Even As Stock Slides After-Hours On Q4 Miss ↗

March 18, 2025

Several optimistic users expressed confidence in the company securing a third potential agreement with a major pharma for its adeno-associated virus (AAV) capsid, STAC-BBB.

Via Stocktwits

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

March 17, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Earnings Scheduled For March 17, 2025 ↗

March 17, 2025

Via Benzinga

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

March 06, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes ↗

February 21, 2025

Pfizer has discontinued Beqvez for hemophilia B due to low patient demand and will focus on alternative treatments, including its approved therapy, Hympavzi.

Via Benzinga

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

February 06, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

January 02, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Sangamo Therapeutics, Inc. (SGMO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

January 02, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

January 02, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide ↗

December 31, 2024

Via Benzinga

Topics Stocks

Stocks Lower Midday As 2024 Comes To An End ↗

December 31, 2024

Stocks are lower midday, as Wall Street heads for its second consecutive winning year.

Via Talk Markets

Topics Stocks / Equities

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet ↗

December 31, 2024

Via Benzinga

US Stocks Open Higher; House Prices Increase In October ↗

December 31, 2024

Via Benzinga

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact ↗

December 31, 2024

Sangamo Therapeutics regains rights to its hemophilia A gene therapy as Pfizer ends their collaboration. The program showed positive Phase 3 results.

Via Benzinga

Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday ↗

December 31, 2024

Via Benzinga

Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.